Quadrature Capital LTD Lantheus Holdings, Inc. Transaction History

Quadrature Capital LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $326,343 - $394,614	3,960 New	3,960 $332,000
Q2 2022 Aug 15, 2022	BUY	$55.54 - $72.65 $177,005 - $231,535	3,187 Added 13.63%	26,570 $1.76 Million
Q1 2022 May 16, 2022	BUY	$24.28 - $56.64 $567,739 - $1.32 Million	23,383 New	23,383 $1.29 Million
Q4 2020 Feb 16, 2021	SELL	$10.75 - $14.91 $125,001 - $173,373	-11,628 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$11.98 - $16.34 $180,909 - $246,750	-15,101 Reduced 56.5%	11,628 $147,000
Q2 2020 Aug 14, 2020	SELL	$10.34 - $15.51 $12,139 - $18,208	-1,174 Reduced 4.21%	26,729 $382,000
Q4 2017 Feb 12, 2018	BUY	$17.4 - $23.4 $189,068 - $254,264	10,866 Added 63.78%	27,903 $0
Q3 2017 Nov 13, 2017	BUY	$15.5 - $19.15 $264,073 - $326,258	17,037	17,037 $0

539

69.9M

651K

459K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Quadrature Capital LTD with notifications on news.